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The combination of mass and normalized elution time (NET) of a peptide identified by liquid
chromatography-mass spectrometry (LC-MS) measurements can serve as a unique signature
for that peptide. However, the specificity of an LC-MS measurement depends upon the
complexity of the proteome (i.e., the number of possible peptides) and the accuracy of the
LC-MS measurements. In this work, theoretical tryptic digests of all predicted proteins from
the genomes of three organisms of varying complexity were evaluated for specificity. Accuracy
of the LC-MS measurement of mass-NET pairs (on a 0 to 1.0 NET scale) was described by
bivariate normal sampling distributions centered on the peptide signatures. Measurement
accuracy (i.e., mass and NET standard deviations of 0.1, 1, 5, and 10 ppm, and 0.01 and
0.05, respectively) was varied to evaluate improvements in process quality. The spatially
localized confidence score, a conditional probability of peptide uniqueness, formed the basis
for the peptide identification. Application of this approach to organisms with comparatively
small proteomes, such as Deinococcus radiodurans, shows that modest mass and elution time
accuracies are generally adequate for confidently identifying most peptides. For more complex
proteomes, more accurate measurements are required. However, the study suggests that the
majority of proteins for even the human proteome should be identifiable with reasonable
confidence by using LC-MS measurements with mass accuracies within 1 ppm and high
efficiency separations having elution time measurements within 0.01 NET. (J Am Soc Mass
Spectrom 2005, 16, 1239–1249) © 2005 American Society for Mass SpectrometryGenomes for more than 100 organisms havebeen sequenced, providing potential proteincoding sequences that could number in the
millions. The introduction of shotgun proteomics, an
approach in which Yates and coworkers have made
critical contributions [1, 2], has greatly increased the
role of mass spectrometry in biological research. The
surge in information that has resulted is presenting
challenges related to the identification of proteins as
well as the desire to increase the throughput of
measurements.
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doi:10.1016/j.jasms.2005.05.009Although the use of tandem mass spectrometry
can often provide confident identifications, there is
increasing interest in higher throughput approaches
that exploit highly accurate mass measurements
[3– 8]. Earlier studies have shown [9, 10] that utilizing
accurate mass spectrometric measurements for MS
based identification of peptides within 0.1 ppm
uncertainty (tolerance) can allow significant levels of
confidence in protein identifications, even from mix-
tures with the complexity of some smaller eukaryotic
systems (e.g., yeast). However, as the genomic, and
thus, the proteomic, complexity of an organism in-
creases, the ability to identify proteins (or peptides)
on the basis of mass measurements alone decreases.
Additional information such as isoelectric point, LC
elution time or, most commonly, the analysis of
peptide fragment ions must be used to distinguish
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[11–14]. Experimental approaches to address this
complexity include more extensive protein or peptide
separations, or focusing on only those peptides with
a specific physical characteristic (e.g., isolation of
cysteinyl peptides by chemical labeling or solid phase
extraction techniques [15–17], and fractionation tech-
niques to add a second separation dimension, e.g.,
MudPIT [2, 18 –23], in addition to the use of peptide
ion fragmentation patterns. While useful, these meth-
ods may decrease analysis throughput, result in
lower protein coverage, or result in specific protein
losses.
When liquid chromatography (LC) separations (e.g.,
using a micro-capillary C18 column) are combined with
high-resolution mass spectrometric measurements, re-
producible peptide elution times can be acquired simul-
taneously with highly accurate mass measurements,
producing informative mass and separation time fea-
tures. The utility of this information increases with the
peak capacity of the separations and the reproducibility
of peptide elution times [24, 25]. Although the absolute
LC elution time of a particular peptide can vary from
run to run because of temperature and flow rate, among
other factors, these changes can largely be corrected
after normalization by using an appropriate algorithm
to align multiple analyses [26, 27].
A peptide’s expected mass and normalized elution
time defines a signature point in the two-dimensional
mass-by-normalized-elution-time space. A reference
database comprised of these signature points can
then be used to identify peptides using high through-
put proteomic analyses by comparing distances from
the measurements to the signature points. If the
database is small, signature points are more likely to
be confidently isolated (i.e., assigned), allowing for
determination of peptide identity. As the database
grows, however, more and more detected species
have near neighbors, and an increasing level of
ambiguity can apply to the identification. Processing
vagaries and measurement errors randomly distrib-
ute replicate measurements about the locale of a
peptide’s true mass and normalized elution time. The
probability distribution describing this scattering of
measurements is called a peptide’s sampling distri-
bution. The sampling distributions of neighboring
peptides may overlap. If a measured mass and elu-
tion time falls within the overlap of the sampling
distributions of two or more peptides, then the iden-
tity of the source peptide will be somewhat ambigu-
ous. The level of ambiguity—the amount of sampling
distribution overlap—may be quantified for each
reference peptide, and for a set of reference peptides,
thus quantifying specificity of the peptides in a
database to the measurements from an LC-MS anal-
ysis.
In this study, bivariate normal sampling distribu-
tions of peptide mass and predicted elution time were
used to evaluate the effects of proteome complexity,mass measurement accuracy, and LC separation time
precision on the confidence of peptide identification.
This work exploits the capability previously developed
to predict the elution times for peptides using an
artificial neural network approach [9]. The present
calculations allow for an estimate of the effectiveness of
the approach for a range of biological systems and
measurement qualities. For this study, elution time
information predicted from theoretical tryptic peptide
sequences [26] at several levels of mass accuracy was
used to determine the likelihood of correctly identifying
a peptide by comparing its mass and elution time with
that of a peptide in a reference database. The applica-
bility of this method to a variety of peptide reference
databases was addressed by comparing four systems of
varying complexity.
Methods
Databases
Protein lists for three organisms—Deinococcus radio-
durans, Saccharomyces cerevisiae, and Homo sapiens—were
obtained from the following protein sequence reposito-
ries: Deinococcus radiodurans (TIGR, March 21, 2000),
Saccharomyces cerevisiae (http://www.yeastgenome.
org/ provided though Stanford University, January 6,
2003), and Homo sapiens (IPI, April 1, 2004). In addition,
a fourth system comprised of the combined proteins
identified from 436 SEQUEST analyses of LC-MS/MS
analyses of human mammary epithelial cells (HMEC)
was used to represent an observed subset of human
proteins (described in an appendix at the end of this
paper). This HMEC dataset represents a set of proteins
that have been observed in the proteome for this human
cell line [28, 29].
Simulated Processing and Analysis
An in silico digestion was performed on the proteins
present in each database using Protein Digestion Sim-
ulator (PDS), a program written in-house using VB.NET
(available online [30]). This program reads a list of
protein names and sequences from an input file and
performs a virtual tryptic digest on each protein se-
quence, then uses an improved version of the normal-
ized elution time (NET) prediction program by Petritis
et al., to compute the predicted NET values for each
sequence [26, 27]. The  in silico tryptic digestion cleaves
each sequence after either lysine or arginine (K or R)
sites, but not if the residue is followed by proline. The
resultant peptides were permitted to have up to one
“missed cleavage” (internal K or R), and were filtered to
only include those with a mass between 600 and 4000
Da. The NET prediction portion of PDS is a VB.NET
DLL that takes as an input a peptide sequence, its
length, and its calculated hydrophobic moment, and
computes the NET for the sequence. The predicted NET
for a given peptide (on a scale of 0 to 1) is determined
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oped with the utilization of training data from 20
species and over 200,000 very high quality peptide
identifications from LC-MS/MS analyses using strictly
controlled separation conditions. Cysteine-only data-
bases were created for each of the four systems by
selecting the subset of cysteine-containing peptides
from the virtual tryptic digests.
The analysis of individual peptide and overall data-
base specificity for each of the reference databases was
achieved by comparing the overlap of peptide sampling
distributions using the spatially localized confidence
scoring (SLiC) method developed by Anderson et al.
[31]. This algorithm estimates the probabilistic distance
between a (mass-NET) measurement and each reference
peptide (mass-NET), and then computes the SLiC score,
the probability (on a 0 to 1 scale) of a match to each
reference peptide conditioned on the peptides in the
reference set. The measurement is identified with the
reference peptide resulting in the largest SLiC score
(probability of a match). For an isolated peptide with no
neighboring peptides and, hence, no overlapping sam-
pling distributions, identifications have a SLiC score of
exactly one. As the number of neighboring peptides or
overlap increases, SLiC score decreases.
SLiC Score Calculation
The statistical basis for the SLiC method is derived from
estimating the probabilistic distance from a measured
mass and time pair, Mi  (mi, ti), to the center of a
sampling distribution, and then applying Bayes theo-
rem to estimate the likelihood that the point is from that
sampling distribution when the results are non-specific
[32].
Suppose that the mass and normalized elution time
measurement, Mi  (mi, ti), for the i
th (mass-elution
time) observation of the jth peptide is bivariate normally
distributed with a mean value, j  (mj, tj) equal to
the jth peptide’s (mass-NET) signature and with covari-
ance j. The standardized distance, dij, from the mea-
surement Mi to the peptide j is computed via
dij
2  (Mi j)
′j1 (Mi j)

(mi mj)
2
mj
2 
(ti tj)
2
tj
2 (1)
under the assumption of independence between the
measurements of mass and normalized elution time. If,
for every signature point, dij is greater than 2.43—
approximately the 95th percentile of the standard biva-
riate normal distribution—for all reference peptides j,
we will consider the ith measurement as unidentifiable.
If we knew the (a priori) probability j that measure-
ments come from the distribution associated with the jth
peptide, then, applying Bayes theorem, the conditional
probability that Mi comes from the j
th peptide, given the
measurement Mi, ispij
jj 1  2exp( dij2 ⁄ 2)

k1
N
kk 1  2exp( dik2 ⁄ 2)
(2)
where N is the number of peptides in the database and
the determinant |j |  mj2 ij2. Because no (a priori)
probabilities are available, we will assume they are all
equally likely (i.e., j  k for all j and k), which yields
pij
(mjtj)
1exp(dij
2 ⁄ 2)

k1
N
(mkik)
1exp(dik
2 ⁄ 2) (3)
Assuming that the database does not contain the en-
tirety of possible peptides in the analyzed sample, we
can admit the possibility that an observed measurement
is from an unreferenced source when the dij values are
large for all reference peptides in the database. Eq 3 will
always assign probabilities, but if dij is greater than 2.43,
we will consider the ith measurement as unidentifiable.
The SLiC scoring method, developed for the appli-
cation of the accurate mass and time (AMT) tag ap-
proach, uses the measured mass and time information
to assist the peptide identification process. The scoring
has two steps. The first step computes the standardized
distance between the measurement and each peptide
signature point and only passes measurements for
possible identification that are less than the critical
distance, dC, in the mass-NET space from one or more
signature points (i.e., AMT tags). Typically, dC  2.4, 3,
or 3.7, corresponding to 95, 99, and 99.9% signature
probability regions. If a measurement is less than the
critical distance from two or more signature points,
then the sampling distributions of those signature
points—each bounded by the critical distance—over-
lap. Identifying the peptide source is now an ambigu-
ous endeavor, a situation that is encountered in the real
application of the approach, increasingly as the level of
complexity increases. To address such ambiguities, the
second step of the SLIC scoring method computes a
score that aims to estimate the likelihood that the
detected species is actually a specific candidate. The
detected species can then be assigned a peptide identi-
fication for the closest peptide if the quality of the
agreement is above a certain (user selected) threshold.
By its formulation, the SLiC scoring method accounts
for sampling distributions defined by instrumental ac-
curacy and their potential overlap. The issues associ-
ated with application of this approach with experimen-
tal measurements will be the focus of a future
publication.
Comparative Analysis Using Defined Mass
and NET Tolerances
To further illustrate the advantages of using a SLiC
score for specificity of identification, a parallel analysis
(data not shown) was performed on the three smallest
databases, D. radiodurans, HMEC, and S. cerevisiae, us-
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function such that a mass-NET pair will either be
unique (no other signature mass-NET point within the
region of tolerance), or it will be non-unique (another
AMT tag on or within the boundary of tolerance). The
results showed that signature points considered unique
by the binary method typically had SLiC scores of 1.0,
but occasionally had scores between 0.98 and 1.0 be-
cause of the presence of neighboring points just outside
the distribution region. A SLiC score is thus represen-
tative of the complexity of the region of mass-NET
space for the measurement and provides a value on a
scale of uniqueness which allows the selection of a
threshold of acceptance (i.e., assignment of a peptide
identification).
For this study, a peptide identification was assigned
if it had a SLiC score 	0.95. Following in silico diges-
tion, each peptide was examined for its uniqueness of
mass and elution time compared with that for all other
peptides of a particular proteome within mass and NET
tolerances of0.1, 1, 5, and 10 ppm and0.01, and 0.05
NET, or without a NET constraint.
Results and Discussion
Information from the analysis of the tryptic peptide and
tryptic cysteinyl peptide databases for each proteome
used in this study is provided in Tables 1 and 2,
respectively. The HMEC example was included to rep-
resent a subset of the human proteome, and is repre-
sentative of applications where only a fraction of the
possible proteins would actually be expressed or exper-
imentally detectable. HMEC is the smallest database,
comprised of 2759 proteins, and the H. sapiens database
is the largest, with 41,216 proteins. That is roughly 13
times the number of proteins in D. radiodurans and 6.5
times more proteins than the S. cerevisiae database
(Table 1). The H. sapiens database also has 13 and 4
times more peptides than the D. radiodurans and S.
cerevisiae databases, respectively. Over 90% of both H.
Table 1. Description of databases of tryptic peptides, mass rang
Database name Proteins
D. radiodurans 3117
S. cerevisiae 6360
H. sapiens 41,216
HMEC subset 2759
Table 2. Description of databases containing cysteine, mass
range 600 to 4000 Da
Database name Cysteinyl peptides
Proteins containing
cysteine
D. radiodurans 9% 67%
S. cerevisiae 16% 89%
H. sapiens 26% 95%
HMEC subset 21% 95%sapiens and HMEC proteins contain cysteine residues,
whereas only 67% of D. radiodurans proteins contain
cysteine residues (Table 2). S. cerevisiae lies between
these two extremes, with 89% cysteine-containing pro-
teins. It should be noted that while the HMEC derived
protein list is smaller than the D. radiodurans protein list,
the HMEC peptide list is more than twice that of D.
radiodurans, because of differences in average protein
size.
Differences in system complexity are readily ob-
served in Figure 1a, where predicted peptide NET
values are plotted against the monoisotopic mass for all
tryptic peptides in each of the four systems. Interest-
ingly, it should be noted that the areas of mass-NET
space that are sparse in peptides differ somewhat
between species. For instance, the sparse region around
0.4 NET and 2500 Da for D. radiodurans contrasts to the
same region for S. cerevisiae that is relatively denser, and
even more sharply to the same region for human (i.e.,
H. sapiens and HMEC), thus reflecting the differences in
amino acid distributions of prokaryotic and eukaryotic
systems. A similar observation applies for regions
above 0.4 NET, as is evident for S. cerevisiae, and to an
even greater extent for H. sapiens. Not surprisingly, the
data for HMEC appear similar to that for S. cerevisiae;
however, S. cerevisiae peptides are more dense than
HMEC in the NET range greater than 0.6, reflecting
subtle differences in abundances of lysine and arginine
and therefore the frequency of trypsin cleavage sites.
When only cysteinyl peptides are considered (Figure
1b) the complexity of all four systems is substantially
reduced compared with the whole proteome (Figure
1a), a significant advantage for approaches that isolate
this subset of peptides. Cysteinyl tryptic peptides in
Figure 1b are also well distributed across mass and NET
values, indicating the viability of this method for ob-
taining a subset of peptides without biasing the sam-
pling to any particular mass-NET region.
The advantage of experimentally isolating cysteinyl
peptides is illustrated in Figure 2. Here, a detailed view
is shown for a common “dense” region of the plots in
Figure 1 for each of the four systems, illustrating the
distribution of peptides by their mass and NET values.
The circles show the two levels of mass and NET
constraints for one cys-peptide (i.e., a signature point)
to illustrate the potential effectiveness for unambiguous
peptide identification. The lower precision constraints
of 5 ppm and 0.05 NET, represented by the larger
to 4000 Da
ues (millions)
Tryptic peptides with 0 or 1
missed cleavages
0.964 125,640
2.99 416,552
19.3 1,683,095
1.63 234,398e 600
Residcircle, include more peptides than the tighter con-
taine
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smaller circle. Figure 2 shows that if only cysteine-
containing peptides are used for peptide identification,
the number of unique peptide choices is reduced by
more than half, effectively doubling the likelihood a
unique peptide will be chosen, illustrated by the dis-
Figure 1. (a) Global representation of tryptic
containing peptides from tryptic digests for all
Time (NET) is plotted along the x-axis, and mon
Inset views are representative of the region conparity of triangles (cysteinyl peptides) compared to dots(non-cysteine containing peptides). In this example, the
point chosen in D. radiodurans is completely isolated
from the other points in the region. The peptide iden-
tification, therefore, is unambiguous, regardless of the
mass and NET constraints used. But for the S. cerevisiae
proteome, three peptides fall within the circle corre-
sts for all four systems studied. (b) Cysteine-
systems studied. Predicted Normalized Elution
ptic mass in Daltons is plotted along the y-axis.
d within 1950–2000 Da and 0.3–0.4 NET.dige
four
oisotosponding to the more relaxed criteria, which presents
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higher mass accuracy and NET precision (inner circle),
the peptide can be distinctly identified. For H. sapiens,
clearly a 5 ppm/0.05 NET tolerance for cysteinyl
peptides generally is not adequate for uniquely identi-
fying peptides in denser regions of mass-NET space, as
indicated by the five peptide species located within the
outer boundary region. However, many unique peptide
identification assignments can be made if tighter con-
straints can be applied. Figure 2 also illustrate the
benefits of using NET and mass information rather than
mass alone. If only mass is used as the criteria for
identification, one encounters more than 20 peptides
having masses within the selected mass region
(2160.002  5 ppm) of the H. sapiens plot in Figure 2.
This phenomenon applies for the other systems, but
because of their smaller proteomes, the number of
ambiguous assignments within a given mass range and
5 ppm accuracy is smaller, and more peptides could
be confidently assigned, particularly from less dense
mass-NET space.
Figure 3 shows a detailed view of peptides from  H.
sapiens, from a dense region of the plot in Figure 2.
The dots represent peptides that do not contain
cysteine, and those that are cysteine-containing are
represented as triangles. In the example shown, two
peptides are located very close to each other, with the
target centered on one peptide (A), while another
peptide (B) is located just outside the smaller circle.
Figure 2. Detailed view of a “dense” region fro
shown as triangles and non-cysteine containing t
comparison in both the H. sapiens and HMEC sub
peptide.With rigid mass and NET constraints of 5 ppm and0.05 NET, defined by the larger region, the four
peptides within this region are effectively indistin-
guishable. However, some assignments in such cases
are more likely to be correct, and this information can
be useful in several ways (e.g., in establishing the
confidence of protein level assignments), and an
approach for gauging ambiguity, e.g., using SLiC
scores, can serve this purpose.
The effect of the mass-NET distance and the number
of neighboring peptides on these scores is illustrated in
Figure 3 based upon either 5 ppm/0.05 NET (outer
circle) or 1 ppm/0.01 NET (inner circle). The under-
lined SLiC scores for points A–C correspond to the
more stringent constraints (inner circle) while the re-
maining scores correspond to the less stringent con-
straints (outer circle). The SLiC scores for the 1 ppm
and 0.01 NET tolerances are only shown for three points
because the remaining points are too far from the
selected peptide and, therefore, have SLiC scores nearly
equal to zero. If an LC-MS analysis detected a peptide of
mass 2160.002 1 ppm having a NET value of 0.5035
0.01, then the SLiC score for peptide A would be 0.96,
while that for peptide B would be 0.04, based upon the
more stringent mass and NET constraints. The SLiC
score of this peptide is not 1 because of the close
proximity of peptide B. Peptide C is farther away, and
therefore its presence has less of an effect on the score
for peptide A. If the less stringent mass and NET
tolerances are used (outer circle), then the presence of
e plots in Figure 1, where cysteinyl peptides are
c peptides as dots. The peptide point chosen for
ystems corresponds to the same cysteinyl trypticm th
rypti
set sall points within that region, as well as the one point
AER,
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score of peptide A to 0.29. In this way, SLiC is repre-
sentative of the density of neighboring points in the
two-dimensional space, and the closeness of each point
to the center. A threshold for SLiC scores can be applied
during data analysis, applying a minimum acceptable
score given the aims of a study and the manner of use.
For example, if high confidence in individual peptide
identifications is desired, then one would use a mini-
mum SLiC score of 0.95 to guarantee that all matches
are solidly unique. If one wanted to allow borderline
matches to pass the filters and use subsequent data
processing steps to sort out the matches (e.g., rollup of
peptides to proteins), then one might choose a lower
SLiC score of 0.75. Thus, the SLiC score can be useful for
the assessment of peptide identifications since it assigns
a confidence value when ambiguities exist.
Figure 4 shows the uniqueness of tryptic peptides
as a function of peptide mass for each system (assum-
ing up to one missed cleavage), at different levels of
mass accuracy and NET precision. The SLiC score is
used to determine the relative position and number
of neighboring peptides for each peptide. If a peptide
had a SLiC score 	0.95, then it was designated as
unique, and the number of unique peptides out of the
total peptides for each mass range was calculated.
The total mass range of 600 – 4000 Da was divided
evenly into 140 binned regions of 25 Da each, and this
range of mass was used for the percentage calcula-
tions. Figure 4 shows that the general trend of
uniqueness is very low at masses less than 1000 Da,
Figure 3. Granular view of dense region from
The SLiC scores for 1 ppm/0.01 NET are unde
for each data point. The peptide sequences for p
VENLEEHSEASNIE, and DDLDEQIRHMLFSWbut increases as the peptide size increases. Loweraccuracy measurements (5 and 10 ppm) are generally
not sufficient to maintain greater than 30% unique-
ness when no NET constraints are applied for any
system. If 50% uniqueness is to be achieved, measure-
ments must be within 0.1 ppm, especially for the
larger proteomes and with no NET measurements.
With a constraint of 0.05 NET, greater than 50% of
unique identifications can be obtained for peptides
greater than 1500 Da for all but the most complex
proteome. With the most stringent NET constraints,
extremely low mass tolerances are not as important to
maintain high levels of peptide distinction. Larger
peptides have a higher uniqueness than smaller pep-
tides, and above 2000 Da at 1 ppm and 0.01 NET,
greater than 75% of peptides from all systems are
unique.
D. radiodurans
With a mass larger than 2000 Da, greater than 50%
uniqueness can be achieved with mass accuracy at or
better than 1 ppm, if no NET constraints are used. With
lower mass accuracy, greater than 50% uniqueness can
only be attained with 5 ppm and at high mass (3500
Da), and 10 ppm accuracy is not sufficient to reach 50%
at any mass. With a NET precision of 0.05, a mass of
at least 2500 Da and mass accuracy of at maximum 5
ppm or a mass greater than 3500 (10 ppm) is required
for 50% of the peptides to be unique. At 0.01 NET
precision, the percent of unique peptides for all but the
lowest mass accuracy and mass greater than 1000 Da
piens. Cys-peptides are represented as triangles.
, while those for 5 ppm/0.05 NET are present
A–C are LVWEEAMSRFCEAEFSVK, FGLLM-
respectively.H. sa
rlined
ointsincreases to 75%.
apien
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In comparison with D. radiodurans, the S. cerevisiae
proteome is larger, and thus the level of measurement
accuracy required for distinct peptide identifications is
increased. If 50% uniqueness is used as the benchmark
of acceptance, then a mass measurement accuracy of 0.1
ppm is sufficient for identifications with or without a
NET measurement. However, if the mass accuracy is 1
ppm, NET measurements with a precision of at least
0.05 must be obtained to reach the benchmark. The
tightest NET constraints (0.01 NET) will allow for
greater than 50% uniqueness with a mass window of 5
ppm for peptides larger than 1500 Da.
HMEC
For HMEC with no NET constraints, a minimum of 1
ppm and a mass greater than 2500 Da is required to
differentiate 50% of the peptides, and at 5 ppm, the best
possible rate is less than 30%, even for large peptides.
To achieve the benchmark of acceptance (50%) for
Figure 4. Percent of peptides that are unique ve
for no NET constraint, and for 0.05 and 0.01 N
The peptides plotted have SLiC scores greater tha
for H. sapiens in addition to all peptides for H. speptides around 1500 Da, mass tolerances of 0.1 or 1ppm must be used, or NET measurements of 0.01, for
mass measurements of 5 ppm.
H. sapiens Using Cysteinyl Peptides
When no NET constraints are employed, the benchmark
of uniqueness is only achieved using 0.1 ppm. With 1
ppm, uniqueness is less than 30%, and lower mass
accuracies are not sufficient to distinguish peptides.
With NET measurements of0.05, a mass accuracy of 1
ppm will reach the benchmark at a peptide mass of 2000
Da. Five ppm accuracy measurements are generally
useful only with the most stringent NET constraint.
H. sapiens
Not surprisingly, tryptic peptides from H. sapiens show
a lower average uniqueness in comparison to the other
systems, attributable to the greater complexity. For the
H. sapiens peptides without the use of a NET constraint,
less than 10% of peptides can be assigned using any
peptide monoisotoptic mass for the four systems
as well as for different levels of mass accuracy.
equal to 0.95. Cysteinyl-only peptides are shown
s.rsus
ET,
n ormass tolerance examined other than 0.1 ppm or except
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precise NET measurements, 1 ppm is still required to
assign 50% peptides at a mass of 1500 Da. This
highlights the advantage of cysteine isolation tech-
niques and high precision elution time measurements.
Conclusions
The use of accurate mass and LC-NET information for
peptide identifications in the context of high through-
put measurements can be effective for addressing pro-
teomes of high complexity. As the accuracy of these two
measurements improves, the extent of protein coverage
by confidently identified peptides also increases. Statis-
tically speaking, peptides have the highest possibility of
being uniquely identified when both the separation and
mass spectrometric measurements are as accurate and
reproducible as possible. Now, high accuracy mass
spectrometers are able to measure masses within a
tolerance of 1 ppm or less, and LC separations have
sufficient run-to-run performance to support the use of
alignment algorithms that yield corrected (e.g., normal-
ized) elution times within 1%. In spite of inherent
uncertainties that apply to accurate mass and NET
measurements, these high specificities provide the basis
for proteomics approaches that combine accurate mass
and NET to identify peptides in a high throughput
manner (i.e., without the need to identify every peptide
using routine MS/MS). These approaches can be fur-
ther augmented by using sample preparation tech-
niques that isolate either cysteinyl peptides or a well-
defined subset of peptides, making them attractive for
studies of the most complex proteomes.
Estimating confidence levels when ambiguities arise
can be accomplished by utilizing the SLiC score. This
score determines to what extent a peptide is isolated in
mass-NET space and can be used to gauge measure-
ment specificity. Such information can aid in determin-
ing the more likely identification when uncertainties are
present. As illustrated herein, the SLiC score allows the
uniqueness of a peptide identification to be assessed by
incorporating a degree of certainty that is more useful
than fixed acceptance criteria, and allows for an accep-
tance threshold to be defined by the researcher to best
suit the needs of the application and downstream data
processing (such as roll-up to the protein level).
The present theoretical approach underestimates
the added complexity of protein modifications and
“partial” tryptic peptides observed in actual pro-
teomics samples. However, this approach does incor-
porate many peptides that will not be observed in
actual samples due to many proteins not being ex-
pressed and/or not being present at detectable levels
(e.g., highly hydrophobic peptides that are underrep-
resented in proteome analyses). While the offset of
these two factors will vary from one situation to
another, we note that to date, the number of peptideswe have experimentally detected in all systems we
investigated has been significantly less than the num-
bers used in this work. The lower numbers are most
likely a manifestation of the finite dynamic range of
measurements or (similarly) a lack of expression of
many proteins.
The present calculations indicate that modest mass
accuracies of 5 ppm and 0.05 NET tolerances will
likely be adequate for identifying the majority of pep-
tides for a given system, and particularly for less
complex proteomes. For more complex proteomes, the
present study provides a basis for estimating the rela-
tive practicality of using the combination of highly
accurate mass and normalized elution measurements to
identify peptides with varying degrees of precision.
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Appendix
Generation of the HMEC Database
HMEC Sample Preparation
The whole cell lysates were split into four groups, each
representing a different focus for identification. Prepa-
ration conditions for each group are summarized be-
low.
Group 1. Global 3D analysis of HMEC. A protein size
exclusion separation was performed, with subsequent
trypsin digestion (Promega, Madison, WI), half using
alkylation by iodoacetamide and half without, followed
by strong cation exchange fractionation (SCX) of each of
the size exclusion fractions and LC-MS/MS analysis of
each SCX fraction This group had 149 samples.
Group 2. Second global analysis. No protein separation
was performed before digestion with trypsin. SCX
fractionation (plus alkylation) was performed, followed
by LC-MS/MS analysis. This group had 67 fractions.
Group 3. Cysteine enrichment global dataset. Same as for
Group 2, except that peptides were first treated using
quantitative cysteinyl-peptide enrichment technique
(QCET) [16] for cysteine enrichment before SCX frac-
tionation. A total of 60 fractions were collected.
1248 NORBECK ET AL. J Am Soc Mass Spectrom 2005, 16, 1239–1249Group 4. Secreted protein sample. The media from four
different growth treatments of HMEC cell samples were
analyzed to target secreted proteins. Each sample was
cleaned, protein isolated, and digested (plus alkylation),
then SCX fractionated. There were 40 fractions for each
of the four samples, for a total of 160 total fractions.
LC-MS Analysis of HMEC Samples
The high-pressure LC (HPLC) system consisted of a
pair of Model 100DM 100-mL syringe pumps and Series
D controller (Isco, Inc., Lincoln, NE), an in-house man-
ufactured stir-bar style mobile phase mixer (2.5-mL
volume), two 4-port, 2-position valves (Valco Instru-
ments Co., Houston, TX) for mobile phase and capillary
column selection, and a 6-port, 2-position Valco valve
equipped with a 10-L sample loop for automated
injections. The mixer and valves were mounted on an
in-house manufactured rack assembly that was custom
fit to a PAL autosampler (Leap Technologies, Carrboro,
NC) for unattended routine analysis. Reversed-phase
capillary HPLC columns were manufactured in-house
by slurry packing 5-m Jupiter C18 stationary phase
(Phenomenex, Torrence, CA) into a 60-cm length of 360
m o.d.  150 m i.d. fused silica capillary tubing
(Polymicro Technologies Inc., Phoenix, AZ) incorporat-
ing a 2-m retaining screen in a 1/16 inch capillary-
bore union (Valco).
The mobile phase consisted of 0.2% acetic acid and
0.05% TFA in water (A) and 0.1% TFA in 90% acetoni-
trile/10%water (B). Mobile phase was degassed with an
in-line Alltech vacuum degasser (Alltech Associates,
Inc., Deerfield, IL). The HPLC system was equilibrated
at 5000 psi with 100% mobile phase A for initial starting
conditions. The mobile phase selection valve was
switched from position A to B 20 min after injection,
creating an exponential gradient as mobile phase B
displaced A in the mixer. An 5-cm length of 360 i.d.
fused silica tubing packed with 5 m C18 was used to
split25 L/min of flow before the injection valve. The
split flow controls gradient speed under conditions of
constant pressure operation. Flow through the capillary
HPLC column was 1.8 L/min when equilibrated to
100% mobile phase A.
MS analysis was performed using a Finnigan model
LCQ Duo or XP ion trap mass spectrometer (Thermo-
Electron Corp., San Jose, CA) with electrospray ioniza-
tion (ESI). The HPLC column was coupled to the mass
spectrometer using an in-house manufactured interface.
No sheath gas or make-up liquid was used. The heated
capillary temperature and spray voltage were 200 °C
and 2.2 kV, respectively. Samples were analyzed over a
mass (m/z) range of 400–2000. For each cycle, the three
most abundant ions from MS analysis were selected for
MS/MS analysis using a collision energy setting of 45%.
Dynamic exclusion was used to discriminate against
previously analyzed ions.HMEC Protein Identifications
A total of 436 LC-MS/MS analyses were performed
with the digested lysate samples. The datasets were
searched against the H. sapiens database using SE-
QUEST [33]. Proteins with 2 or more peptides of high
confidence (XCorr 	 1.9, 2.2, and 3.75 for 1, 2, and
3 charge states, respectively), a mass between 500 and
4000 Da, and no more than one missed tryptic cleavage
were compiled, resulting in a list of 2759 unique pro-
teins. The peptide confidence criteria used here are
similar to those used by the Yates and coworkers [2, 33].
This protein list was then treated in the same manner as
the protein lists that were downloaded for the other
three systems.
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